LAVA Therapeutics (LVTX) Competitors

FitLife Brands (NASDAQ:FTLF) and LAVA Therapeutics (NASDAQ:LVTX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Do analysts rate FTLF or LVTX?

FitLife Brands currently has a consensus target price of $20.50, suggesting a potential upside of 43.56%. LAVA Therapeutics has a consensus target price of $3.17, suggesting a potential upside of 141.73%. Given LAVA Therapeutics' higher possible upside, analysts clearly believe LAVA Therapeutics is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33
LAVA Therapeutics	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the MarketBeat Community prefer FTLF or LVTX?

LAVA Therapeutics received 22 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 64.10% of users gave LAVA Therapeutics an outperform vote while only 50.00% of users gave FitLife Brands an outperform vote.

Company	Underperform	Outperform
FitLife Brands	Outperform Votes 3 50.00%	Underperform Votes 3 50.00%
LAVA Therapeutics	Outperform Votes 25 64.10%	Underperform Votes 14 35.90%

Do institutionals and insiders believe in FTLF or LVTX?

2.3% of FitLife Brands shares are held by institutional investors. 61.3% of FitLife Brands shares are held by insiders. Comparatively, 9.5% of LAVA Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has more risk and volatility, FTLF or LVTX?

FitLife Brands has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, LAVA Therapeutics has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500.

Which has better valuation and earnings, FTLF or LVTX?

FitLife Brands has higher revenue and earnings than LAVA Therapeutics. LAVA Therapeutics is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$63.86M	2.10	$5.30M	$0.84	17.00
LAVA Therapeutics	$4.99M	6.91	-$41.97M	-$1.04	-1.26

Does the media favor FTLF or LVTX?

In the previous week, FitLife Brands had 1 more articles in the media than LAVA Therapeutics. MarketBeat recorded 2 mentions for FitLife Brands and 1 mentions for LAVA Therapeutics. LAVA Therapeutics' average media sentiment score of 1.43 beat FitLife Brands' score of 0.44 indicating that LAVA Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
FitLife Brands	Neutral
LAVA Therapeutics	Positive

Is FTLF or LVTX more profitable?

FitLife Brands has a net margin of 13.38% compared to LAVA Therapeutics' net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat LAVA Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	13.38%	28.03%	15.13%
LAVA Therapeutics	N/A	-62.22%	-29.37%

Summary

FitLife Brands beats LAVA Therapeutics on 14 of the 19 factors compared between the two stocks.